A Janus kinase (JAK) inhibitor outperformed tumor necrosis factor (TNF) blockers for substantially reducing rheumatoid arthritis (RA) symptoms in patients for whom conventional anti-rheumatic drugs ...
LONDON (Reuters) - In a change of tack, Britain's healthcare cost watchdog NICE has recommended the use of Bristol-Myers Squibb's rheumatoid arthritis drug Orencia by the state health service ...
(Reuters) - Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey ...
A Colorado panel voted Friday to cap the price for a best-selling drug from Amgen. It is one of four states that have passed legislation allowing price caps for specific prescriptions.
Delaying MTX initiation by 4 weeks after PCV13 vaccination significantly improved humoral responses in patients with RA, without compromising disease control.
Researchers explored the impact of polypharmacy on long-term treatment response among patients with early rheumatoid arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback